Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage
Insud Pharma · Post Partum Hemorrhage
Phase 2
Not yet recruiting
330
2026-04
Industry sponsor intelligence
Insud PharmaClinical Pipeline.
Lead-sponsor view of Insud Pharma's indexed peptide studies, development phases, active programs, completed work and recent registry changes.
- Total
- 1
- Recruiting
- 0
- Active
- 1
- Completed
- 0
- Results posted
- 0
- Avg enrollment
- 330
Pipeline overview
Programs by phase and activity.
Velocity
Insud Pharma trials by start year
Study start year · indexed snapshot
Development
Trials by phase
1phase labels
Early Phase 10
Phase 10
Phase 21
Phase 30
Phase 40
| Product | Studies | Early / I | Phase II | Phase III | Phase IV | Active |
|---|---|---|---|---|---|---|
| Oxytocin → | 1 | 0 | 1 | 0 | 0 | 1 |
Active peptide trials
In motion now.
NCT IDStudyPhase / statusEnrollmentUpdated
Completed trials
Finished registry records.
No studies in this snapshot.
Search sponsor records
All Insud Pharma studies.
This page groups studies where Insud Pharma is listed as the lead industry sponsor. Collaborator-only records are not included in the count.
1 matching study
Last registry update first
Recent updates